Author: Pretorius, E.; Venter, C.; Laubscher, G. J.; Lourens, P. J.; Steenkamp, J.; Kell, D. B.
Title: Prevalence of amyloid blood clots in COVID-19 plasma Cord-id: d5amygv5 Document date: 2020_7_29
ID: d5amygv5
Snippet: The rapid detection of COVID-19 uses genotypic testing for the presence of SARS-Cov-2 virus in nasopharyngeal swabs, but it can have a poor sensitivity. A rapid, host-based physiological test that indicated whether the individual was infected or not would be highly desirable. Coagulaopathies are a common accompaniment to COVID-19, especially micro-clots within the lungs. We show here that microclots can be detected in the native plasma of COVID-19 patient, and in particular that such clots are a
Document: The rapid detection of COVID-19 uses genotypic testing for the presence of SARS-Cov-2 virus in nasopharyngeal swabs, but it can have a poor sensitivity. A rapid, host-based physiological test that indicated whether the individual was infected or not would be highly desirable. Coagulaopathies are a common accompaniment to COVID-19, especially micro-clots within the lungs. We show here that microclots can be detected in the native plasma of COVID-19 patient, and in particular that such clots are amyloid in nature as judged by a standard fluorogenic stain. This provides a rapid and convenient test (P<0.0001), and suggests that the early detection and prevention of such clotting could have an important role in therapy.
Search related documents:
Co phrase search for related documents- low specificity and lung opacity: 1
- low specificity high sensitivity and lung opacity: 1
Co phrase search for related documents, hyperlinks ordered by date